Monoethanolamine oleate: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Rabin Bista (talk | contribs) No edit summary |
||
| Line 48: | Line 48: | ||
| density = 0.974 | | density = 0.974 | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}}{{AE}}{{SS}} | {{CMG}}{{AE}}{{SS}} | ||
== Overview == | |||
'''Monoethanolamine oleate''' (properly '''ethanolammonium oleate''') is an [[antivaricose]] agent. It is a [[salt (chemistry)|salt]] formed by [[Brønsted-Lowry acid-base theory|Lowry-Brønsted acid-base]] reaction between [[monoethanolamine]] and [[oleic acid]], is [[IUPAC nomenclature|systematically named]] 2-hydroxyethylammonium (9''Z'')-octadecenoate, and has a [[structural formula]] [CH<sub>3</sub>(CH<sub>2</sub>)<sub>7</sub>CH=CH(CH<sub>2</sub>)<sub>7</sub>CO<sub>2</sub>][H<sub>3</sub>NCH<sub>2</sub>CH<sub>2</sub>OH]. It is injected topically into [[varicose vein|varicosities]] to cause [[Sclerosis (medicine)|sclerosis]] (closure) of the abnormal vein. | '''Monoethanolamine oleate''' (properly '''ethanolammonium oleate''') is an [[antivaricose]] agent. It is a [[salt (chemistry)|salt]] formed by [[Brønsted-Lowry acid-base theory|Lowry-Brønsted acid-base]] reaction between [[monoethanolamine]] and [[oleic acid]], is [[IUPAC nomenclature|systematically named]] 2-hydroxyethylammonium (9''Z'')-octadecenoate, and has a [[structural formula]] [CH<sub>3</sub>(CH<sub>2</sub>)<sub>7</sub>CH=CH(CH<sub>2</sub>)<sub>7</sub>CO<sub>2</sub>][H<sub>3</sub>NCH<sub>2</sub>CH<sub>2</sub>OH]. It is injected topically into [[varicose vein|varicosities]] to cause [[Sclerosis (medicine)|sclerosis]] (closure) of the abnormal vein. | ||
| Line 58: | Line 59: | ||
[[Category:Ammonium compounds]] | [[Category:Ammonium compounds]] | ||
[[Category:Carboxylate anions]] | [[Category:Carboxylate anions]] | ||
[[Category:Cardiovascular Drugs]][[Category:Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drugs]] | |||
Latest revision as of 19:18, 15 April 2015
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | Multum Consumer Information |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C20H41NO3 |
| Molar mass | 343.54444 g/mol |
| Density | 0.974 g/cm3 |
  (what is this?) (verify) | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Overview
Monoethanolamine oleate (properly ethanolammonium oleate) is an antivaricose agent. It is a salt formed by Lowry-Brønsted acid-base reaction between monoethanolamine and oleic acid, is systematically named 2-hydroxyethylammonium (9Z)-octadecenoate, and has a structural formula [CH3(CH2)7CH=CH(CH2)7CO2][H3NCH2CH2OH]. It is injected topically into varicosities to cause sclerosis (closure) of the abnormal vein.
Categories:
- Pages with script errors
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- Articles with changed DrugBank identifier
- Articles with changed ChemSpider identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles with non-default infobox title
- Articles without EBI source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Ammonium compounds
- Carboxylate anions
- Cardiovascular Drugs
- Drugs